Search Results - "Nasu, Akihiro"

Refine Results
  1. 1

    Two Cases of Hepatocellular Carcinoma Occurring Immediately after Direct-acting Antiviral Agents against Hepatitis C Virus by Nishijima, Norihiro, Nasu, Akihiro, Kimura, Toru, Osaki, Yukio

    Published in Internal Medicine (15-01-2019)
    “…We experienced two cases of hepatocellular carcinoma (HCC) occurring immediately after treatment with direct-acting antiviral agents (DAAs). Case 1 was a…”
    Get full text
    Journal Article
  2. 2

    Long‐term antitumor effect of lenvatinib on unresectable hepatocellular carcinoma with portal vein invasion by Takeda, Haruhiko, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Kita, Ryuichi, Kimura, Toru, Kudo, Masatoshi, Osaki, Yukio

    Published in Hepatology research (01-05-2019)
    “…Lenvatinib is a novel multikinase inhibitor that has recently shown antitumor activity against hepatocellular carcinoma (HCC) in a phase III trial. We report…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Dynamics of hepatitis B virus quasispecies in association with nucleos(t)ide analogue treatment determined by ultra-deep sequencing by Nishijima, Norihiro, Marusawa, Hiroyuki, Ueda, Yoshihide, Takahashi, Ken, Nasu, Akihiro, Osaki, Yukio, Kou, Tadayuki, Yazumi, Shujiro, Fujiwara, Takeshi, Tsuchiya, Soken, Shimizu, Kazuharu, Uemoto, Shinji, Chiba, Tsutomu

    Published in PloS one (16-04-2012)
    “…Although the advent of ultra-deep sequencing technology allows for the analysis of heretofore-undetectable minor viral mutants, a limited amount of information…”
    Get full text
    Journal Article
  6. 6

    Genetic heterogeneity of hepatitis C virus in association with antiviral therapy determined by ultra-deep sequencing by Nasu, Akihiro, Marusawa, Hiroyuki, Ueda, Yoshihide, Nishijima, Norihiro, Takahashi, Ken, Osaki, Yukio, Yamashita, Yukitaka, Inokuma, Tetsuro, Tamada, Takashi, Fujiwara, Takeshi, Sato, Fumiaki, Shimizu, Kazuharu, Chiba, Tsutomu

    Published in PloS one (22-09-2011)
    “…The hepatitis C virus (HCV) invariably shows wide heterogeneity in infected patients, referred to as a quasispecies population. Massive amounts of genetic…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Dynamics of Defective Hepatitis C Virus Clones in Reinfected Liver Grafts in Liver Transplant Recipients: Ultradeep Sequencing Analysis by Ohtsuru, Shigeru, Ueda, Yoshihide, Marusawa, Hiroyuki, Inuzuka, Tadashi, Nishijima, Norihiro, Nasu, Akihiro, Shimizu, Kazuharu, Koike, Kaoru, Uemoto, Shinji, Chiba, Tsutomu

    Published in Journal of Clinical Microbiology (01-11-2013)
    “…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Recent progress in radiofrequency ablation therapy for hepatocellular carcinoma by Ikeda, Kenji, Osaki, Yukio, Nakanishi, Hiroyuki, Nasu, Akihiro, Kawamura, Yusuke, Jyoko, Koji, Sano, Takatomo, Sunagozaka, Hajime, Uchino, Koji, Minami, Yasunori, Saito, Yu, Nagai, Kazumasa, Inokuchi, Ryosuke, Kokubu, Shigehiro, Kudo, Masatoshi

    Published in Oncology (01-01-2014)
    “…In order to attain better ablation and more effective management of hepatocellular carcinoma (HCC), new approaches and devices in radiofrequency ablation (RFA)…”
    Get more information
    Journal Article
  12. 12

    Effect of treatment with branched-chain amino acids during sorafenib therapy for unresectable hepatocellular carcinoma by Takeda, Haruhiko, Nishikawa, Hiroki, Iguchi, Eriko, Ohara, Yoshiaki, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Kita, Ryuichi, Kimura, Toru, Osaki, Yukio

    Published in Hepatology research (01-03-2014)
    “…Aim To examine the effect of branched‐chain amino acid (BCAA) therapy for patients with unresectable hepatocellular carcinoma (HCC) treated with sorafenib…”
    Get full text
    Journal Article
  13. 13

    Clinical significance of pretreatment serum interferon-gamma-inducible protein 10 concentrations in chronic hepatitis C patients treated with telaprevir-based triple therapy by Nishikawa, Hiroki, Enomoto, Hirayuki, Nasu, Akihiro, Aizawa, Nobuhiro, Saito, Masaki, Tamori, Akihiro, Kawada, Norifumi, Kimura, Toru, Osaki, Yukio, Nishiguchi, Shuhei

    Published in Hepatology research (01-12-2014)
    “…Aim We aimed to determine whether pretreatment serum interferon‐γ‐inducible protein (IP)‐10 concentration can predict response to telaprevir (TVR)‐based triple…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma: clinical outcome and safety in elderly patients by Nishikawa, Hiroki, Kita, Ryuichi, Kimura, Toru, Ohara, Yoshiaki, Takeda, Haruhiko, Sakamoto, Azusa, Saito, Sumio, Nishijima, Norihiro, Nasu, Akihiro, Komekado, Hideyuki, Osaki, Yukio

    Published in Journal of Cancer (01-01-2014)
    “…The aim of our study was to compare clinical outcomes between elderly patients aged ≥75 years (elderly group, n=66) with intermediate hepatocellular carcinoma…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    De novo hepatitis B virus infection in hepatocellular carcinoma following eradication of hepatitis C virus by interferon therapy by Nasu, Akihiro, Marusawa, Hiroyuki, Ueda, Yoshihide, Eso, Yuji, Umeda, Makoto, Chiba, Tsutomu, Osaki, Yukio

    Published in Hepatology research (01-06-2010)
    “…Epidemiological studies have revealed that hepatocellular carcinoma (HCC) is still observed in hepatitis C virus (HCV)‐positive patients with a sustained…”
    Get full text
    Journal Article
  19. 19
  20. 20